Terms: = Ovarian cancer AND SEPT5, HCDCREL-1, 5413, ENSG00000184702, Q99719, PNUTL1, H5 AND Treatment
1 results:
1. Tamoxifen-2-hydroxylpropyl-beta-cyclodextrin-aggregated nanoassembly for nonbreast estrogen-receptor-positive cancer therapy.
Shukla J; Sharma U; Kar R; Varma IK; Juyal S; Jagannathan NR; Bandopadhyaya GP
Nanomedicine (Lond); 2009 Dec; 4(8):895-902. PubMed ID: 19958226
[TBL] [Abstract] [Full Text] [Related]
